SE8900899L - Peptider foer diagnostisk anvaendning - Google Patents

Peptider foer diagnostisk anvaendning

Info

Publication number
SE8900899L
SE8900899L SE8900899A SE8900899A SE8900899L SE 8900899 L SE8900899 L SE 8900899L SE 8900899 A SE8900899 A SE 8900899A SE 8900899 A SE8900899 A SE 8900899A SE 8900899 L SE8900899 L SE 8900899L
Authority
SE
Sweden
Prior art keywords
thr
glu
lys
gly
ile
Prior art date
Application number
SE8900899A
Other languages
Unknown language ( )
English (en)
Other versions
SE465573B (sv
SE8900899D0 (sv
Inventor
L Olson
Original Assignee
Lope Medicine Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lope Medicine Ab filed Critical Lope Medicine Ab
Priority to SE8900899A priority Critical patent/SE465573B/sv
Publication of SE8900899D0 publication Critical patent/SE8900899D0/sv
Priority to AU53393/90A priority patent/AU5339390A/en
Priority to PCT/SE1990/000149 priority patent/WO1990010644A1/en
Publication of SE8900899L publication Critical patent/SE8900899L/sv
Publication of SE465573B publication Critical patent/SE465573B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/48Nerve growth factor [NGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
SE8900899A 1989-03-14 1989-03-14 Nervtillvaextfaktorpeptider, motsvarande antikroppar och foerfarande foer bestaemning av nativ nervtillvaextfaktor SE465573B (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE8900899A SE465573B (sv) 1989-03-14 1989-03-14 Nervtillvaextfaktorpeptider, motsvarande antikroppar och foerfarande foer bestaemning av nativ nervtillvaextfaktor
AU53393/90A AU5339390A (en) 1989-03-14 1990-03-08 Peptides and antibodies for the detection of ngf (nerve growth factor) and/or precursors thereof
PCT/SE1990/000149 WO1990010644A1 (en) 1989-03-14 1990-03-08 Peptides and antibodies for the detection of ngf (nerve growth factor) and/or precursors thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8900899A SE465573B (sv) 1989-03-14 1989-03-14 Nervtillvaextfaktorpeptider, motsvarande antikroppar och foerfarande foer bestaemning av nativ nervtillvaextfaktor

Publications (3)

Publication Number Publication Date
SE8900899D0 SE8900899D0 (sv) 1989-03-14
SE8900899L true SE8900899L (sv) 1990-09-15
SE465573B SE465573B (sv) 1991-09-30

Family

ID=20375340

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8900899A SE465573B (sv) 1989-03-14 1989-03-14 Nervtillvaextfaktorpeptider, motsvarande antikroppar och foerfarande foer bestaemning av nativ nervtillvaextfaktor

Country Status (3)

Country Link
AU (1) AU5339390A (sv)
SE (1) SE465573B (sv)
WO (1) WO1990010644A1 (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1239270B (it) * 1990-02-27 1993-10-01 Fidia Spa Metodo per la determinazione quantitativa della forma biologicamente attiva del fattore di crescita nervoso umano in liquidi proteici
IT1243281B (it) * 1990-06-12 1994-05-26 Fidia Spa Metodo per la determinazione quantitativa e qualitativa di polipeptidiin liquidi proteici
US5958875A (en) * 1996-03-29 1999-09-28 The Regents Of The University Of California Synthetic peptides derivatives with nerve growth factor-like neurotrophic activity
US9498530B2 (en) 2002-12-24 2016-11-22 Rinat Neuroscience Corp. Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
CN102746399B (zh) 2002-12-24 2016-03-02 里纳特神经***学公司 抗ngf抗体及其使用方法
WO2005019266A2 (en) 2003-07-15 2005-03-03 Amgen Inc. Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
ITRM20030601A1 (it) 2003-12-24 2005-06-25 Lay Line Genomics Spa Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti.
ME00226B (me) 2004-07-15 2011-02-10 Medarex Llc Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
ITRM20050290A1 (it) * 2005-06-07 2006-12-08 Lay Line Genomics Spa Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
EP2448970B1 (en) 2009-05-04 2014-07-09 Abbott Research B.V. Antibodies against nerve growth factor (ngf) with enhanced in vivo stability

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989009225A1 (en) * 1988-03-28 1989-10-05 The Regents Of The University Of California Nerve growth factor peptides

Also Published As

Publication number Publication date
WO1990010644A1 (en) 1990-09-20
SE465573B (sv) 1991-09-30
SE8900899D0 (sv) 1989-03-14
AU5339390A (en) 1990-10-09

Similar Documents

Publication Publication Date Title
BR0016066A (pt) Compostos e métodos para tratamento e diagnóstico de infecção clamidial
SE7906148L (sv) Forfarande for framstellning av en biologisk komposition for anvendning sasom referenskontroll vid diagnostiska tester
ZA872166B (en) Synthetic htlv-iii peptides,compositions and uses thereof
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
ATE108022T1 (de) Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
ES2120416T3 (es) Inhibidores del crecimiento tumoral derivados de tejidos, metodos de preparacion y usos de dichos inhibidores.
ES2047334T3 (es) Metodo de analisis optico.
FI84107C (sv) HbA1c:s immunologiska bestämningsförfarande som innefattar denaturerin g
DE59008337D1 (de) Vorrichtung zur Bestimmung von Festigkeitseigenschaften von langgestrecktem, textilem Prüfgut.
SE8900899D0 (sv) Peptides for diagnostic use
DE69433378D1 (de) Humane b-lymphoblastoiden zellinie welche anti-gangliosid-antikörper sekretiert
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
ES2079621T3 (es) Procedimiento de identificacion o de titulacion de proteinas y aplicaciones.
DK0457804T3 (da) M-CSF-monoklonale antistoffer, som genkender en neutraliserende, konformational epitop
DE69030494D1 (de) Karzinomverwandtes haptoglobin (hpr)
NO177463C (no) STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve
DE69333560D1 (de) Transport und expression eines hybriden oberflächenproteins an der oberfläche von grampositiven bakterien
DE3879085D1 (de) Snrnp-a-antigen und fragmente davon.
HK1021229A1 (en) A in vitro method of determining the presence of aprotein in an isolated biological sample.
DE69529272D1 (de) MONOKLONALER ANTIKÖRPER GEGEN DAS HUMANE Mx-PROTEIN MxA
ES2074983T3 (es) Procedimieto para el aislamiento de proteinas de membranas basales a partir de tejidos humanos y animales.
DE69534263D1 (de) Expression kassette eines proteines p30 aus toxoplasma gondii
SE8704765L (sv) Immunologiskt aktiva polypeptider, anvendbara for framstellning av antimalariavacciner och diagnostest for pavisande av antisporozoantikroppar
DE3587542D1 (de) Verfahren zur Diagnose in vitro von menschlichen Cytomegalovirusinfektionen und Anwendung von monoklonalen Antikörpern gegen Cytomegaloviren, die mit einer cytomegalovirusinduzierten Proteinkinase reagieren.
DE69229948D1 (de) hGPIIb-FRAGMENTE UND IHRE VERWENDUNG IN IN-VITRO-VERFAHREN ZUR BESTIMMUNG VON IN VIVO STATTFINDENDEN THROMBOTISCHEN EREIGNISSEN

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8900899-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8900899-9

Format of ref document f/p: F